4 tips to conducting a successful digital marketing pharma campaign
In a world that operates across a digital platform, it’s important for today’s pharma and medical device companies to integrate digital marketing into their business plan.
One, if not the most, important aspect of digital marketing is social media. Pharma companies need to leverage social media for one prominent reason: that’s where patients and consumers are.
When social media first began to be discussed by health care professionals back in 2009, clarification from the FDA on proper use of social channels for pharmaceutical marketing was minimal. Driven by the rise of mobile devices and the increasing reliance of the Internet for medical information, the FDA has since updated its guidelines for using social media platforms and released its FDA Draft Guidance for Internet/Social Media Platforms with Character Space Limitations last year.
Because more patients, and health care professionals alike, are relying on social and mobile platforms to solve health care challenges than ever before, pharmaceutical marketers need to adapt to this change in media consumption and engage with their audiences under these terms.
RELATED TOPIC: 4 reasons why social media empowers your medical practice
Cadient’s Gene Y. Miller shares the following four tips to striking a balance between an effective marketing campaign that also includes appropriate safety and risk disclosures.
1. Say a lot in a few words.
Economize the amount of space you have by using abbreviation, punctuation marks and symbols (such as “&”).
2. Include primary and secondary links.
Primary links should direct to a site that provides more complete information about risk, while a secondary link can be included for additional information.
RELATED TOPIC: How social media is shaping modern health care
3. Consider the platform.
Twitter is not the right forum for every pharma marketing message. If the proper risk/benefit balance cannot be achieved in the constraints of Twitter, or any other social media forum, Miller says that perhaps that platform should not be used for that particular message.
4. Keep the FDA in mind.
When composing your message, keep it short and sweet. Include the benefit, communicate the risk and use the full FDA-approved name.
RELATED TOPIC: Top 5 digital health giants you should be watching
With the average number of tweets by pharma companies increasing by 530 percent since 2013, according to Ogilvy Healthworld, and Twitter followers in return increasing by nearly 300 percent, it comes as no surprise that more companies are seeing the value of incorporating social media into their digital marketing strategies.
[SOURCE: Pharma Compliance Monitor]
Jvion launches AI-powered map to tackle mental health crisis
Clinical AI company Jvion has launched an interactive map of the US that highlights areas that are most vulnerable to poor mental health.
The Behavioral Health Vulnerability Map uses Jvion's AI CORE™ software to analyse public data on social determinants of health (SDOH) and determine the vulnerability of every US Census block group.
Vulnerability refers to the likelihood that residents will experience issues like self-harm, suicide attempts or overdoses. The map also identifies the most influential social determinants in each region, to show the social and environmental conditions that contribute to mental illness.
As an example, the map shows that Harrison County in Mississippi has a 50% higher suicide rate than the rest of the state. It also shows a high percentage of individuals in the armed forces at a time when active duty suicides are at a six-year high, along with a high prevalence of coronary artery disease, arthritis, and COPD, all chronic illnesses that are linked to a higher suicide risk.
The map also shows Harrison County has a high percentage of Vietnamese Americans, who studies suggest have high rates of depression and may be less likely to seek help from mental health professionals.
The map was built using the same data and analytics that Jvion used to create the COVID Community Vulnerability Map, which was launched towards the start of the pandemic.
With this new map, Jvion is aiming to tackle the growing mental health crisis in the US. “At a time when so many Americans are struggling with their mental health, we’re proud to offer a tool that can help direct treatment resources to the communities that need it most,” said Dr John Showalter, MD, Jvion’s chief product officer, who led the development of the map.
“For too long, the healthcare industry has struggled to address social determinants of health, particularly in the context of behavioural health. Our hope is that by surfacing the social and environmental vulnerabilities of America’s communities, we can better coordinate our response to the underlying conditions that impact the health and wellbeing of people everywhere.”